Executive Actions Tracker

This EO directs the Centers for Disease Control and Prevention and its Advisory Committee on Immunization Practices to review an HHS scientific assessment comparing U.S. childhood vaccine recommendations with those of peer nations and to take appropriate steps to update the U.S. childhood and adolescent vaccine schedule, with consideration of flexibility for parents and doctors in timing and sequencing. It further directs all executive departments and agencies to align actions, regulations, funding, and coverage with the ACIP-recommended, CDC-adopted schedule, including continued coverage of scheduled immunizations without cost sharing by private insurance and coverage under Medicaid, the Children's Health Insurance Program, and the Vaccines for Children Program. It also directs the HHS Director of the Office of Intergovernmental and External Affairs to inform state officials of the order's policies and make the scientific assessment available to inform state vaccination laws.

Clients in Healthcare · Life Sciences · Insurance

This EO directs the expedited rescheduling of marijuana from Schedule I to Schedule III, acknowledging its accepted medical use and reduced abuse potential. It further calls for a regulatory framework and improved research on both medical marijuana and hemp-derived CBD products, including clear guidance on THC limits and accurate product labeling. The order aims to close gaps in medical knowledge so patients and providers may access safe, effective, and well-informed treatment options.

Clients in Cannabis · Healthcare · Life Sciences

This memorandum directs federal health officials to review childhood vaccine recommendations from peer, developed countries and update U.S. guidelines if superior, evidence-based practices are identified, while maintaining access to all currently available vaccines.

Clients in Healthcare · Life Sciences

This memorandum directs the Secretary of Health and Human Services to take immediate steps to eliminate waste, fraud, and abuse in the Medicaid program, particularly by ending state-directed payment schemes that inflate Medicaid reimbursements far above Medicare levels. The President orders alignment of Medicaid payment rates with Medicare, where legally permissible, to protect the program’s financial sustainability and ensure fairness across federal healthcare systems.

Clients in Healthcare

This memorandum directs the Secretaries of Labor and Health and Human Services and the Commissioner of Social Security, in consultation with the Secretary of Homeland Security, to ensure ineligible aliens do not receive Social Security Act funds, including by prioritizing civil or administrative enforcement against States, localities, and grantees that fail to verify eligibility. It directs the Attorney General and the Commissioner to expand the SSA's fraud prosecutor program to at least 50 U.S. Attorney Offices, and the Attorney General and the Secretary of Health and Human Services to establish a similar program for Centers for Medicare and Medicaid Services programs in at least 15 offices, both by October 1, 2025. It further directs the Commissioner to implement the recommendations of SSA Inspector General Audit Report A-06-21-51022, refer mismatched earnings reports for persons age 100 or older to the Inspector General, and, within 60 days, review resuming civil monetary penalties under section 1129 of the Social Security Act.

Clients in Healthcare

This EO seeks to optimize Federal health care programs, intellectual property protections, and safety regulations to provide access to prescription drugs at lower costs. The EO directs various agency actions to achieve this goal.

Clients in Healthcare · Life Sciences

This EO states that the Federal Government will promote universal access to clear and accurate healthcare prices. The Secretaries of the Treasury, Labor, and HHS are directed to take all necessary and appropriate action to rapidly implement and enforce the healthcare price transparency regulations issued pursuant to Executive Order 13877 (June 24, 2019, Improving Price and Quality Transparency in American Healthcare to Put Patients First) to require the disclosure of the actual prices of items and services, not estimates, issue updated guidance or proposed regulatory action ensuring pricing information is standardized and easily comparable across hospitals and health plans, and issue guidance or proposed regulatory action updating enforcement policies designed to ensure compliance with the transparent reporting of complete, accurate, and meaningful data within 90 days.

Clients in Healthcare · Insurance

This EO directs all executive departments and agencies that address health or healthcare to focus on reversing chronic disease, including the following actions: all federally funded health research should use transparency and open-source data and eliminate conflicts of interest; NIH and other federal health research initiatives should prioritize research on chronic illness; agencies should work with farmers to ensure US food is healthy, abundant, and affordable; and agencies should ensure availability of expanded treatment options and flexible insurance coverage for lifestyle changes/disease prevention. Further, the Make America Healthy Again Commission is established with the initial mission to advise the President how to address childhood chronic disease (reports due in 100 days and 180 days).

Clients in Healthcare · Life Sciences · Food and Beverage

This EO states that "it is the policy of the United States that it will not fund, sponsor, promote, assist, or support the so-called “transition” of a child from one sex to another, and it will rigorously enforce all laws that prohibit or limit these destructive and life-altering procedures." The EO directs specific actions at HHS, DoD, and DOJ to enforce this, including stopping insurance support, reviewing policies, and requiring this policy for all federally funded organizations.

Clients in Healthcare · Life Sciences · Insurance